Westpac Banking Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.3M | Buy |
2,614
+85
| +3% | +$37.7K | 0.08% | 194 |
|
|
2026
Q1 | $1.13M | Sell |
2,529
-76
| -3% | -$35.4K | 0.08% | 194 |
|
|
2025
Q4 | $1.18M | Buy |
2,605
+131
| +5% | +$56.5K | 0.07% | 206 |
|
|
2025
Q3 | $969K | Sell |
2,474
-271
| -10% | -$113K | 0.06% | 218 |
|
|
2025
Q2 | $1.22M | Buy |
2,745
+72
| +3% | +$33.2K | 0.08% | 198 |
|
|
2025
Q1 | $1.3M | Sell |
2,673
-609
| -19% | -$284K | 0.1% | 200 |
|
|
2024
Q4 | $1.32M | Sell |
3,282
-124
| -4% | -$57.5K | 0.09% | 201 |
|
|
2024
Q3 | $1.58M | Buy |
3,406
+128
| +4% | +$61.5K | 0.11% | 184 |
|
|
2024
Q2 | $1.54M | Buy |
3,278
+381
| +13% | +$165K | 0.12% | 157 |
|
|
2024
Q1 | $1.21M | Sell |
2,897
-659
| -19% | -$279K | 0.09% | 189 |
|
|
2023
Q4 | $1.45M | Buy |
3,556
+83
| +2% | +$30.7K | 0.12% | 171 |
|
|
2023
Q3 | $1.21M | Sell |
3,473
-3,076
| -47% | -$1.08M | 0.09% | 205 |
|
|
2023
Q2 | $2.3M | Sell |
6,549
-38,130
| -85% | -$12.8M | 0.16% | 167 |
|
|
2023
Q1 | $14.1M | Sell |
44,679
-5,349
| -11% | -$1.6M | 0.19% | 139 |
|
|
2022
Q4 | $14.4M | Buy |
50,028
+13,809
| +38% | +$4.21M | 0.21% | 126 |
|
|
2022
Q3 | $10.5M | Sell |
36,219
-3,850
| -10% | -$1.11M | 0.16% | 168 |
|
|
2022
Q2 | $11.3M | Sell |
40,069
-1,502
| -4% | -$402K | 0.15% | 184 |
|
|
2022
Q1 | $10.8M | Buy |
41,571
+15,571
| +60% | +$3.7M | 0.12% | 225 |
|
|
2021
Q4 | $5.71M | Sell |
26,000
-73
| -0.3% | -$14.2K | 0.06% | 382 |
|
|
2021
Q3 | $4.73M | Sell |
26,073
-42,566
| -62% | -$8.31M | 0.05% | 428 |
|
|
2021
Q2 | $13.8M | Buy |
68,639
+4,542
| +7% | +$950K | 0.14% | 179 |
|
|
2021
Q1 | $13.8M | Buy |
64,097
+359
| +0.6% | +$78.9K | 0.15% | 169 |
|
|
2020
Q4 | $15.1M | Buy |
63,738
+27,140
| +74% | +$6.23M | 0.17% | 146 |
|
|
2020
Q3 | $9.96M | Buy |
36,598
+3,285
| +10% | +$906K | 0.13% | 188 |
|
|
2020
Q2 | $9.67M | Sell |
33,313
-5,899
| -15% | -$1.6M | 0.14% | 179 |
|
|
2020
Q1 | $9.33M | Buy |
39,212
+14,704
| +60% | +$3.37M | 0.16% | 168 |
|
|
2019
Q4 | $5.37M | Buy |
24,508
+2,116
| +9% | +$428K | 0.07% | 371 |
|
|
2019
Q3 | $3.79M | Hold |
22,392
| – | – | 0.05% | 422 |
|
|
2019
Q2 | $4.11M | Sell |
22,392
-47,461
| -68% | -$8.3M | 0.06% | 347 |
|
|
2019
Q1 | $12.8M | Sell |
69,853
-37,819
| -35% | -$6.99M | 0.21% | 132 |
|
|
2018
Q4 | $17.8M | Sell |
107,672
-6,256
| -5% | -$1.08M | 0.3% | 88 |
|
|
2018
Q3 | $22M | Sell |
113,928
-18,638
| -14% | -$3.32M | 0.38% | 66 |
|
|
2018
Q2 | $22.5M | Sell |
132,566
-577
| -0.4% | -$89.4K | 0.43% | 57 |
|
|
2018
Q1 | $21.7M | Buy |
133,143
+16,991
| +15% | +$2.78M | 0.43% | 56 |
|
|
2017
Q4 | $17.4M | Buy |
116,152
+40,100
| +53% | +$5.94M | 0.4% | 64 |
|
|
2017
Q3 | $11.6M | Buy |
76,052
+42,281
| +125% | +$6.36M | 0.25% | 99 |
|
|
2017
Q2 | $4.35M | Sell |
33,771
-17,855
| -35% | -$2.15M | 0.1% | 297 |
|
|
2017
Q1 | $5.65M | Sell |
51,626
-1,563
| -3% | -$138K | 0.05% | 403 |
|
|
2016
Q4 | $4.33M | Buy |
53,189
+3,000
| +6% | +$244K | 0.04% | 397 |
|
|
2016
Q3 | $4.38M | Buy |
50,189
+2,986
| +6% | +$282K | 0.05% | 370 |
|
|
2016
Q2 | $4.06M | Buy |
47,203
+16,187
| +52% | +$1.4M | 0.04% | 403 |
|
|
2016
Q1 | $2.47M | Buy |
31,016
+20,415
| +193% | +$1.85M | 0.03% | 438 |
|
|
2015
Q4 | $1.33M | Sell |
10,601
-26,919
| -72% | -$3.25M | 0.01% | 529 |
|
|
2015
Q3 | $3.91M | Buy |
37,520
+4,119
| +12% | +$529K | 0.04% | 347 |
|
|
2015
Q2 | $4.12M | Sell |
33,401
-4,097
| -11% | -$516K | 0.04% | 332 |
|
|
2015
Q1 | $5.15M | Buy |
37,498
+664
| +2% | +$79.6K | 0.04% | 359 |
|
|
2014
Q4 | $4.38M | Sell |
36,834
-1,300
| -3% | -$146K | 0.04% | 389 |
|
|
2014
Q3 | $4.28M | Buy |
38,134
+22,500
| +144% | +$2.14M | 0.04% | 371 |
|
|
2014
Q2 | $1.48M | Sell |
15,634
-128
| -0.8% | -$8.98K | 0.01% | 547 |
|
|
2014
Q1 | $1.11M | Sell |
15,762
-59,300
| -79% | -$4.7M | 0.01% | 550 |
|
|
2013
Q4 | $5.58M | Buy |
75,062
+61,551
| +456% | +$4.29M | 0.06% | 285 |
|
|
2013
Q3 | $1.02M | Sell |
13,511
-1,528
| -10% | -$122K | 0.01% | 560 |
|
|
2013
Q2 | $1.07M | Buy |
+15,039
| New | +$1.11M | 0.02% | 539 |
|
Other funds holding VRTX
Westpac Banking Corp's VRTX Position: Q2 2026 in Review
Westpac Banking Corp increased its Vertex Pharmaceuticals (VRTX) stake by 3.4% in Q2 2026, buying an estimated $37.7K and bringing the position to 2,614 shares worth $1.3M. The position accounts for 0.08% of the portfolio, ranked #194.
Westpac Banking Corp first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.5M in Q2 2018. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Westpac Banking Corp held 2,614 shares of Vertex Pharmaceuticals worth $1.3M as of Q2 2026.
- Westpac Banking Corp bought 85 Vertex Pharmaceuticals shares in Q2 2026, an estimated $37.7K.
- Vertex Pharmaceuticals made up 0.08% of Westpac Banking Corp's portfolio in Q2 2026, its #194 holding.
- Westpac Banking Corp first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Westpac Banking Corp's Vertex Pharmaceuticals position peaked at $22.5M in Q2 2018.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Westpac Banking Corp's 13F filing for Q2 2026, filed 12 Aug 2026.